In conclusion, U87MG, a mesenchymal GBM cell line with GPM metabolic background, responded with increased apoptosis after MET + LPS + TMZ treatment via increased ER stress and UPR response and downregulation of BCL2. The gene discussed is BCL2; the disease is glioblastoma.